HSI (MANCHESTER) LIMITED

Company number 15077251 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

HSI (MANCHESTER) LIMITED - Analysis Report

Company Number: 15077251

Analysis Date: 2025-07-20 14:49 UTC

Financial Health Assessment for HSI (MANCHESTER) LIMITED


1. Financial Health Score: D

Explanation:
HSI (MANCHESTER) LIMITED shows a concerning financial profile primarily due to a significant imbalance between current assets and current liabilities, resulting in a large working capital deficit. While the company holds a valuable investment property asset, the short-term liquidity position is under substantial stress. The financial health score of D reflects symptoms of liquidity strain and potential cash flow challenges despite having positive net assets.


2. Key Vital Signs

Metric Value (£) Interpretation
Current Assets 372 Extremely low liquid assets, indicating minimal available cash and receivables for short-term use.
Cash 272 Very low cash balance, insufficient to cover immediate obligations.
Debtors 100 Minimal receivables, suggesting limited incoming cash flow from customers or tenants.
Current Liabilities 948,795 Very high short-term obligations, primarily due to related party creditors and deferred income.
Net Current Assets (Working Capital) -948,423 Negative working capital—critical symptom of liquidity distress, indicating inability to cover short-term debts.
Total Assets Less Current Liabilities 27,024 Positive net assets driven by investment property, but overshadowed by current liabilities.
Shareholders' Funds (Equity) 27,024 Small equity base relative to liabilities, signaling limited buffer against financial shocks.
Investment Property Value 975,447 Substantial fixed asset representing the company’s core long-term investment.

3. Diagnosis: What the Financial Data Reveals

HSI (MANCHESTER) LIMITED is in the early stages of operation (incorporated August 2023) and has invested heavily in an investment property valued at approximately £975,000. However, the company’s liquidity — the “cash in the bloodstream” of the business — is severely compromised. With current liabilities exceeding £948,000 and current assets just £372, the company faces a critical shortfall in liquid resources to meet immediate obligations.

The high current liabilities include significant balances owed to related parties (£898,889 combined), implying the company relies on intra-group financing or supplier credit. This dependence can be a double-edged sword: it may provide short-term relief but presents a risk if these creditors demand repayment suddenly.

Despite this liquidity strain, the positive net assets and shareholders' funds reflect an underlying asset base, mainly the investment property, which is a strong foundation if managed carefully. The directors express a "going concern" stance, anticipating sufficient resources to continue operations, but the "symptoms" of liquidity distress require vigilant cash flow management.


4. Recommendations: Specific Actions to Improve Financial Wellness

  • Improve Liquidity Management:
    Prioritize increasing cash reserves and receivables collection. Consider renegotiating payment terms with creditors, especially related parties, to extend short-term liabilities or convert some into longer-term loans to ease immediate cash flow pressure.

  • Leverage Investment Property:
    Explore options to unlock value from the investment property asset, such as leasing to generate regular rental income or refinancing to access cash for working capital needs.

  • Monitor Related Party Transactions:
    Ensure transparency and formalize agreements with related entities to avoid governance issues and potential conflicts of interest. Aim to reduce reliance on related party creditors over time.

  • Enhance Financial Planning and Reporting:
    Implement robust budgeting and cash flow forecasting to anticipate liquidity bottlenecks early and plan accordingly.

  • Consider Equity Injection:
    If feasible, an injection of equity capital from shareholders or new investors could bolster working capital and strengthen the balance sheet.


Medical Analogy Summary

The company’s financial "heartbeat" shows a strong asset (investment property) but very weak "blood flow" (cash and liquid assets), indicating symptoms of acute liquidity distress. Without intervention to improve its "circulatory system," the risk of "financial shock" remains high. However, with proper management and strategic actions, there is potential for recovery and sustainable "financial health."


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.